Assorted news from the last week: Data from an ongoing Phase 1 Pacific Pediatric Neuro-Oncology Consortium (PNOC) network study sponsored by the Dana-Farber Cancer Institute
Assorted news from the last week: CAC2 Member Joe Baber urges community members to take immediate action to secure Senate passage of the Creating Hope
Assorted news from the last week: With Election Day behind us, Congress may be in a better position now to enact another round of stimulus
Assorted news from the last week: Children with birth defects who were conceived via in vitro fertilization (IVF) were more likely to develop childhood cancer
[vc_row][vc_column][vc_column_text] Assorted news from the last week: The International Cancer Research Partnership (ICRP) published results from its Impact of Covid-19 on childhood cancer research funding organizations
Assorted news from the last week: This year’s Cancer Grand Challenges (funded by Cancer Research UK and the National Cancer Institute) include a category for
Assorted news from the last week: Researchers at Baylor College of Medicine and the University of North Carolina at Chapel Hill have genetically modified human
Assorted news from the last week: Twenty percent of children treated with drugs called anthracyclines go on to suffer heart failure later in life. Dr.
[vc_row][vc_column][vc_column_text] Assorted news from the last week: In a Swedish study of how families in pediatric oncology experienced illness‐related information and communication with professionals and within
[vc_row][vc_column][vc_column_text] Assorted news from the last week: A study by a French research team found “that treatment with growth hormones is not associated with an
